Footprint-based identification of viral entry inhibitors targeting HIVgp41 Mr. Holden 9/18/2012.

Slides:



Advertisements
Similar presentations
Solange Arazi Caillaud. MD Emiliano Bissio. MD María Ester Lázaro. MD.
Advertisements

ARV failure and resistance for the paediatrician
April 15 Understanding HIV Treatment and adherence. The African Eye Trust HIV Treatment Information Event By Badru Male&Elijah Amooti.
Pre Test !!!!!!. How many classes of HIV meds are currently available?
Antiretroviral drugs in UMMC Presenter: TE CHIN YEW Preceptor: KHOO SU LIN.
HIV to AIDS Adam Jones. Main Theories THEORY 1 –Began in 1940 in Africa Thought hunters were butchering monkeys that had SIV, a disease with similar characteristic.
Timothy Clark Medicinal Chemistry
Treating HIV with Azidothymidine (AZT) A Design by Jeanine Nasser.
ANTIRETROVIRAL THERAPY Dr. Samuel Mwaniki (BPharm., MSc TID, UoN) University of Nairobi ISO 9001: Certified
+ Antiretroviral Agents: HIV & AIDS Shaw Vonder Hoya.
Rachel Cohen, Regional Executive Director, DNDi North America Proposals for a Global Innovation System that Responds to Patients Needs and Ensures Both.
HIV Lifecycle and Mechanisms of Antiretroviral Therapy
Dr Emmanuel Nsutebu Consultant Infectious Diseases Physician Tropical and Infectious Diseases Unit Royal Liverpool Hospital HIV “Myths, controversies and.
Human Immunodeficiency Virus and Antiretroviral Therapy
DHS/HIV/PP HIV/AIDS 2007 Update David H. Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine Division of Infectious.
Drugs for HIV/AIDS management Dorothy Rodriguez, Emmelisa Gonzalez, Wilfrido Cordova.
Presented by: Siti Rohaizah bt Othman. Arv DRUGS AVAILABLE IN UMMC Combivir (Lamivudine + Zidovudine) Stocrin (Efavirenz 600mg) Kaletra (Lopinavir 200mg.
HIV = Human Immunodeficiency Virus
Antiviral Drugs: HIV treatment Zach Laucis April 17 th, 2007.
ANTIRETROVIRAL RESISTANCE Jennifer Fulcher, MD, PhD.
1. What is the most common mode of HIV transmission? 2. How else is HIV transmitted? 3. What is the most common mode of work related transmission? p.
STDS AND HIV ARE 100% PREVENTABLE WITH ABSITENCE.
Ardis Ann Moe, M.D. UCLA CARE clinic/NEVHC Van Nuys HIV Clinic 28 August 2015.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 93 Antiviral Agents II: Drugs for HIV Infection and Related.
RITONAVIR INTERACTIONS AND SIDE EFFECTS Present by PEERAKARN BANJERDKIJ.
Aids Facts About Prevention. Disease Facts Found in tears, saliva,nervous system tissue, spinal fluid, and breast milk.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
© IAS–USA Johnson VA et al. Top Antivir Med. 2011;19(4): Updates, user notes, and references available at Mutations in the.
Virsuses: Human Immunodeficiency Syndrome & Acquired Immunodeficiency Syndrome.
Anti-HIV Drugs Melissa Morgan Medicinal Chemistry November 23, 2004.
What is the current status of AIDS World Wide? Meagan Munson.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV Principles in Primary Care and Triage of the HIV patient David Aymond, MD, AAHIVM.
HIV/AIDS. What is HIV? H – Human – can only infect human beings. I – Immunodeficiency – HIV weakens your immune system by destroying important cells that.
Current Concepts in HIV/AIDS A Pharmacy Perspective Carol Schneiderman, Pharm D Clinical Pharmacist, University of Arizona.
Altman et al. JACS 2008, Presented By Swati Jain.
1 HIV Drugs, Updates, & the Hope for Entry Inhibitors Kent Williams Doctor of Pharmacy Candidate 2011 Wingate University School of Pharmacy Saturday, February.
The Life and Times of Anitvirals By: Karen Summers Louise Pilsbury Jasmine Delaine Irfan Mekic Bethannie Jamerson.
Antiretroviral Update Sarah Ryan, PharmD February 17, 2010.
Highly Active Antiretroviral Therapy (HAART) Cocktail Therapy
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
HIV: WHAT IS NEW? DR NYA EBAMA, M.D. LOWCOUNTRY INFECTIOUS DISEASES, PA CARETEAM PLUS, INC SEPTEMBER 18, 2015.
Virsuses: Human Immunodeficiency Syndrome & Acquired Immunodeficiency Syndrome.
Antiretroviral targets in the viral life cycle Viral Replication and Drug targets.
Basics of Human Immunodeficiency Virus (HIV) Brian Rybarczyk, PhD University of North Carolina- Chapel Hill.
Acyclovir Lee, sang-hwi.
항바이러스제 Ritonavir 양혜란. Ritonavir 화학명 1,3-Tiazol-5-ylmethyl[3-hydroxy-5-[3-methyl-2-[methyl-[(2-propan-2- yl-1,3-thiazole-4-yl)methyl]carbamoyl]-aminobutanoyl]amino-1,6-
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
 The Life Cycle of HIV  Step 1: Binding and Fusion  Drugs which affect this: › Fusion inhibitors › CCR5 Inhibitors
Retrovirus HIV (humans) Animal viruses resulting in cancer / AIDS 15-39%
© IAS–USA Johnson VA et al. Top Antivir Med. 2013;21(1):4-12. Updates, user notes, and references available at Mutations in the Reverse.
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
ALFREDO MARTINEZandCLAUDIA TORRES. Human Immunodeficiency Virus First human infection estimated around 1930 First known HIV case occurred in person who.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
Ardis Ann Moe, M.D. UCLA CARE clinic/NEVHC Van Nuys HIV Clinic 29 August 2014.
Phase 3 Treatment-Naïve and Treatment-Experienced
Med Chem Tutoring January 25
Antiretroviral Therapy (ART)
Mutations in the Reverse Transcriptase Gene Associated With Resistance to Reverse Transcriptase Inhibitors Nucleoside and Nucleotide Analogue Reverse Transcriptase.
ART 101 Successful HIV treatment usually consists of at least three drugs from two different “classes” of ARV drugs There are now six classes of ARV drugs:
Once Daily Etravirine versus Efavirenz in Treatment-Naive SENSE Trial
Dustin Wilson, PharmD, BCPS Assistant Professor of Pharmacy Practice
HIV/AIDS By: Khatiga Shervani , Karla Molina, Tiffany Cordero, and Claribel Torres Ms. Green and Ms. Geshke Period 3.
School of Pharmacy, University of Nizwa
Mutations in the Reverse Transcriptase Gene Associated With Resistance to Reverse Transcriptase Inhibitors Nucleoside and Nucleotide Analogue Reverse Transcriptase.
ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals ACTIVITY CODE TD342.
Antiretroviral therapy and its complications
Terminology HIV AIDS Acquired Human Immune Immunodeficiency Deficiency
Tertiary structures of HIV-1 reverse transcriptase and chemical formulas of NRTIs and NNRTIs. (A) HIV-1 RT complexed with dsDNA and zidovudine triphosphate.
Presentation transcript:

Footprint-based identification of viral entry inhibitors targeting HIVgp41 Mr. Holden 9/18/2012

Paper Holden, P. M.; Kaur, H.; Gochin, M.; Rizzo, R. C. Footprint-based identification of HIVgp41 inhibitors, Bioorg. Med. Chem. Lett., 2012, 22, 3011–3016 dx.doi.org/ /j.bmcl dx.doi.org/ /j.bmcl

Outline The AIDS/HIV epidemic Current treatments HIVgp41 DOCKing – What is it, how it functions, scoring functions Footprints – a new scoring function Methods Results Conclusion and Future Work

AIDS/HIV Statistics CDC – as of 2009, estimated 1,148,200 people living with HIV in the US

Current Treatments Non-nucleoside reverse transcriptase inhibitors (NNRTIs). NNRTIs disable a protein needed by HIV to make copies of itself. Examples include efavirenz (Sustiva), etravirine (Intelence) and nevirapine (Viramune). Nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs are faulty versions of building blocks that HIV needs to make copies of itself. Examples include Abacavir (Ziagen), and the combination drugs emtricitabine and tenofovir (Truvada), and lamivudine and zidovudine (Combivir). Protease inhibitors (PIs). PIs disable protease, another protein that HIV needs to make copies of itself. Examples include atazanavir (Reyataz), darunavir (Prezista), fosamprenavir (Lexiva) and ritonavir (Norvir). Entry or fusion inhibitors. These drugs block HIV's entry into CD4 cells. Examples include enfuvirtide (Fuzeon) and maraviroc (Selzentry). Integrase inhibitors. Raltegravir (Isentress) works by disabling integrase, a protein that HIV uses to insert its genetic material into CD4 cells. Text from: and-drugs (Bold added for emphasis) and-drugs

HIVgp41 PNAS September 25, 2001 vol. 98 no

HIVgp41 as a protein 6 Helix Bundle Inner coiled-coil is target Highly-conserved binding pocket

Docking – How it works Each molecule is broken by rotatable bonds The scaffold is positioned in the pocket The fragments are then added in layers to the scaffold At each stage, scaffold and fragments are minimized

Docking - Scoring To score molecules, scoring function uses two parameters – Electrostatic Interactions – Van der Waals Interactions Also use footprint descriptor score – To be discussed later

Interlude – Van Der Waals and Electrostatics Electrostatics – interaction between charges – Each atom is assigned a partial charge – These are summed over all atoms interacting Van Der Waals – attraction or repulsion between electron clouds

New Scoring Function - Footprints

Why use footprints? Can tailor the docking results to a user input – Find molecules that mimic: A native substrate An existing drug A composite of drug properties – Can focus just on van der waals or electrostatics or the sum of both

Flowchart of Experiment

Docking Results - Example Examples of different docked molecules and footprints Reference side chains in green

Docking Results – Top Scoring Molecules

Fluorescence Binding Assay Molecule to be tested is dissolved and mixed with a modified gp41 protein If it inhibits the protein, the fluorescently tagged protein fragment is released and then the fluorescence is measured (think p-glow lab) Biol Chem.Biol Chem Apr;387(4):

Resulting Leads All values in micromolar (uM)

Conclusions and Future Work Seven currently-identified leads Multiple Projects – Lead Refinement through computational work – Co-crystallize with HIVgp41 for accurate picture – Denovo design using footprints Must obtain nanomolar activity before moving forward with drug trials